Volpara Scorecard

Volpara Health
Volpara is a software application intended for use with digital breast x-ray systems, including tomosynthesis. Volpara calculates and quantifies volumetric breast density as a ratio of fibroglandular tissue and total breast volume estimates. Volpara provides these numerical values along with a BI-RADS breast density 4th or 5th Edition category to aid health care professionals in the assessment of breast tissue composition.
volpara-health-volparadensity_3.png
volpara-health-volparadensity_4.png
volpara-health-volparadensity_5.png
volpara-health-volparadensity.jpg
volpara-health-volparadensity_1.jpg
volpara-health-volparadensity_2.png
volpara-health-volparadensity_3.png
volpara-health-volparadensity_4.png
volpara-health-volparadensity_5.png
volpara-health-volparadensity.jpg
volpara-health-volparadensity_1.jpg
volpara-health-volparadensity_2.png
Information source: Vendor
Last updated: November 24, 2024

General Information

General
Product name Volpara Scorecard
Company Volpara Health
Subspeciality Breast
Modality Mammography
Disease targeted Breast cancer
Key-features Breast density quantification, BI-RADS, BI-RADS breast density category
Suggested use After: diagnosis verification

Technical Specifications

Data characteristics
Population Breast screening population
Input 2D Full-Field Digital Mammography, 3D Digital Breast Tomosynthesis​
Input format DICOM
Output DICOM structured report
Output format DICOM
Technology
Integration Integration in standard reading environment (PACS), Integration RIS (Radiological Information System)
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time 10 - 60 seconds

Regulatory

Certification
CE
Certified, Class I , MDD
FDA 510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE) VolparaDensity is a software application intended for use with the raw data from digital breast x-ray systems, including tomosynthesis. VolparaDensity calculates and quantifies a density map and from that determines volumetric breast density as a ratio of fibroglandular tissue and total breast volume estimates. VolparaDensity provides these numerical values along with a BI-RADS breast density 4th or 5th Edition category to aid health care professionals in the assessment of breast composition. VolparaDensity is not an interpretive or diagnostic aid and should be used only as adjunctive information when the final assessment of breast density category is made by an MQSA-qualified interpreting physician.

Market

Market presence
On market since 10-2010
Distribution channels Lunit
Countries present (clinical, non-research use) 36
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, Subscription, One-off payment
Based on Number of users, Number of installations, Number of analyses

Evidence

Evidence
Peer reviewed papers on performance

  • Mammographic density assessment: comparison of radiologists, automated volumetric measurement, and artificial intelligence-based computer-assisted diagnosis (read)

  • Supplemental MRI Screening for Women with Extremely Dense Breast Tissue (read)
Non-peer reviewed papers on performance

  • Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer (read)

  • A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model (read)
Other relevant papers

  • Digital mammographic density and breast cancer risk: a case–control study of six alternative density assessment methods (read)